Profile
ATRS ISRG BDXA BDX ALC RMD
Company Name Antares Pharma, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap - $192.04B $55.91B $53.26B $37.61B $37.14B
Employees 0.20K 15.64K 0.00K 70.00K 25.60K 9.98K
CEO Robert Apple Gary S. Guthart - Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
ATRS ISRG BDXA BDX ALC RMD
Quant Rating Score 4 3 5 3 3 4
Quant Rating Buy Neutral Strong Buy Neutral Neutral Buy
Trading
ATRS ISRG BDXA BDX ALC RMD
Last Close $5.59 $537.59 $59.24 $181.52 $73.6 $253.62
High 52 $5.59 $610.45 $59.24 $249.08 $98.3 $293.73
Low 52 $5.59 $429.59 $59.24 $165.15 $72.05 $204.58
Price vs. 52 Week High 0 % -11.94 % 0 % -27.12 % -25.13 % -13.66 %
Price vs. 52 Week Low 0 % 25.14 % 0 % 9.91 % 2.15 % 23.97 %
Total Return
ATRS ISRG BDXA BDX ALC RMD
1 Month Return 0 % 20.2 % 0 % -3.02 % -1.21 % -7.35 %
3 Month Return 0 % 7.41 % 0 % -0.01 % -17.49 % -8.58 %
6 Month Return 0 % 4.05 % 0 % -12.35 % -24.69 % 7.09 %
9 Month Return 0 % -7.34 % 0 % -26.95 % -20.28 % -1.56 %
YTD Return 0 % 2.99 % 0 % -19.99 % -13.3 % 10.9 %
1 Year Return 0 % 4.64 % 0 % -23.28 % -21.09 % 4.36 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ATRS ISRG BDXA BDX ALC RMD
Dividend Yield Percentage (TTM) - - 2.26 % 2.24 % 0.44 % 0.86 %
Dividend Paid and Capex Coverage Ration (TTM) 5.53 % 4.3 % 1.73 % 1.73 % 3.26 % 4.34 %
Dividend Per Share (TTM) - - 4.16 % 4.16 % 0.33 % 2.19 %
Payout Ratio (TTM) - - 73.1 % 73.1 % 15.71 % 22.19 %
Growth
ATRS ISRG BDXA BDX ALC RMD
Asset Growth 21.16 % 8.54 %
Gross Profit Growth 33.76 % 11.69 %
Revenue Growth 22.98 % 4.16 %
Revenue 3 Year 177.1 % 5.3 %
Revenue 5 Year 220.91 % 8.72 %
Revenue 10 Year 537.22 % 59.37 %
EBIT Growth 354.27 % 19.82 %
Net Income Growth -17.64 % 14.89 %
Net Income 3 Yeari Growth Per Share 780.1 % -18.63 %
Net Income 5 Yeari Growth Per Share 273.24 % 28.82 %
Net Income 10 Yeari Growth Per Share 701.34 % -4.02 %
Operating Income Growth 357.24 % 13.55 %
Operating Cash Flow Growth (CFG) 71.76 % 27.07 %
Operating 3 Year CFG 302.36 % -18.4 %
Operating 5 Year CFG 319.52 % 6.25 %
Operating 10 Year CFG 1183.81 % 45.28 %
EPS Growth -18.18 % 18.31 %
EPS Diluted Growth -18.18 % 18.62 %
Book Value Per Share 47.55 % -0.85 %
Share Holder 3 Year Equity Growth Per Share 331.37 % 9.16 %
Share Holder 5 Year Equity Growth Per Share 254.05 % 14.4 %
Share Holder 10 Year Equity Growth Per Share 221.7 % 241.78 %
Dividend Per Share Growth - -2.44 %
Dividend 3 Year Growth Per Share - 4.79 %
Dividend 5 Year Growth Per Share - 4.14 %
Dividend 10 Year Growth Per Share - 74.3 %
Debt Growth -43.11 % 31.74 %
Free Cash Flow Growth 347.46 % 45.25 %
Updated On 31 Dec 2021 30 Sep 2024
Profitability
ATRS ISRG BDXA BDX ALC RMD
Gross Profit Margin TTM 62.89 % 66.41 % 45.08 % 45.08 % 55.13 % 59.36 %
Return on Assets TTM 17.98 % 14.19 % 2.93 % 2.93 % 3.42 % 17.14 %
Return on Equity TTM 31.4 % 16.08 % 6.31 % 6.31 % 4.93 % 25.51 %
Return on Capital Employed TTM 31.36 % 16.05 % 5.78 % 5.78 % 4.98 % 23.55 %
Net Income Per EBT TTM 74.33 % 86.77 % 83.91 % 83.91 % 85.57 % 83.5 %
EBT Per Ebit TTM 100 % 112.41 % 70.86 % 70.86 % 86.96 % 99.54 %
EBIT Per Revenue TTM 33.85 % 29.3 % 12.63 % 12.63 % 14.38 % 32.75 %
Cash Flow To Debt Ratio TTM 152.88 % - 16.82 % 16.82 % 39.27 % 198.52 %
Receivables Turnover TTM 2.22 7.63 7.27 7.27 4.98 5.48
Payables Turnover TTM 4 11.09 1.85 1.85 5.03 7.52
Inventory Turnover TTM 5.91 1.81 2.97 2.97 1.88 2.25
Fixed Asset Turnover TTM 707.22 % 186.61 % 313.67 % 313.67 % 197.54 % 716.47 %
Asset Turnover TTM 71.45 % 49.67 % 38.95 % 38.95 % 31.94 % 62.96 %
Operating Cash Flow Per Share TTM 0.22 8.3 11.3 11.3 4.16 11.96
Free Cash Flow Per Share TTM 0.18 6.37 8.85 8.85 3.23 11.32
Cash Per Share TTM 39.47 % 1376.56 % 262.85 % 262.85 % 284.33 % 825.72 %
Operating Cash Flow Sales Ratio TTM 19.9 % 30.8 % 15.22 % 15.22 % 20.57 % 34.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 81.93 % 76.72 % 78.37 % 78.37 % 77.51 % 94.7 %
Cash Flow Coverage Ratios TTM 152.88 % - 16.82 % 16.82 % 39.27 % 198.52 %
Price To Free Cash Flows Ratio TTM - 84.55 20.71 20.89 23.53 22.39
Price To Operating Cash Flows Ratio TTM 25.97 64.75 16.3 16.45 18.27 21.21
Price Cash Flow Ratio TTM 25.97 64.75 16.3 16.45 18.27 21.21
Income Statement (TTM)
ATRS ISRG BDXA BDX ALC RMD
Revenue $0.18B $8.35B $20.18B $20.18B $9.91B $5.15B
Gross Profit $0.12B $5.63B $9.13B $9.13B $5.51B $3.05B
Gross Profit Ratio 62.89% 67.46% 45.22% 45.22% 55.61% 59.36%
EBITDA $0.07B $2.81B $4.82B $4.82B $2.68B $1.91B
Net Income $0.05B $2.32B $1.71B $1.71B $1.02B $1.4B
EPS Diluted 0.27 6.42 5.86 5.86 2.05 9.51
Balance Sheet (MRQ)
ATRS ISRG BDXA BDX ALC RMD
Long Term Debt $0.02B $0.11B $18.61B $18.61B $4.97B $0.81B
Total Liabilities $0.08B $2.31B $31.4B $31.4B $8.79B $2.21B
Total Equity $0.18B $16.53B $25.89B $25.89B $21.55B $5.97B
Total Investments $0B $7.05B $0.45B $0.45B $0.91B $0.09B
Total Debt $0.02B $0.15B $20.92B $20.92B $5.14B $0.88B
Total Assets $0.26B $18.84B $57.29B $57.29B $30.35B $8.17B
Cash Flow Statement (TTM)
ATRS ISRG BDXA BDX ALC RMD
Net Income $0.05B $2.34B $1.71B $1.71B $1.02B $1.4B
Inventory $0B $-0.83B $0.1B $0.1B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.31B
Operating Cash Flow $0.04B $2.42B $3.8B $3.8B $2.08B $1.75B
Capital Expenditure $-0.01B $-1.11B $-0.73B $-0.73B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 74.25
ANGO AngioDynamics, Inc. 12.135
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 124.26
ATRC AtriCure, Inc. 34.07
ATRI Atrion Corporation 459.92
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 11.05
AZTA Azenta, Inc. 29.91
BAX Baxter International Inc. 19.175
BDX Becton, Dickinson and Company 179.285
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.155
BLFS BioLife Solutions, Inc. 26.91
COO The Cooper Companies, Inc. 70.1
DXR Daxor Corporation 13.36
EKSO Ekso Bionics Holdings, Inc. 5.09
FEMY Femasys Inc. 0.6185
ETFs With Exposure to ATRS
Ticker ETF Name Weight Percentage Price
VFLQ Vanguard U.S. Liquidity Factor ETF 0.06 99.7611
VQNPX Vanguard Growth and Income Fund 0 74.19
VGIAX Vanguard Quantitative Funds - Vanguard Growth and Income Fund 0 121.1
PQSG PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF 0.2 72.5283
STSB iShares Factors US Small Blend Style ETF 0.07 22.13
JKK iShares Morningstar Small-Cap Growth ETF 0.03 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
APXH Two Roads Shared Trust - APEX HealthCare ETF 0.26 8.87
Unlock